Amedisys, Inc. (AMED) Is At $75.00 Formed Wedge; Cardiovascular Systems (CSII) Sellers Decreased By 3.56% Their Shorts

Amedisys, Inc. (NASDAQ:AMED) Logo

Cardiovascular Systems Inc (NASDAQ:CSII) had a decrease of 3.56% in short interest. CSII’s SI was 1.14 million shares in May as released by FINRA. Its down 3.56% from 1.18M shares previously. With 212,400 avg volume, 5 days are for Cardiovascular Systems Inc (NASDAQ:CSII)’s short sellers to cover CSII’s short positions. The SI to Cardiovascular Systems Inc’s float is 3.45%. The stock decreased 1.02% or $0.315 during the last trading session, reaching $30.515. About 40,855 shares traded. Cardiovascular Systems, Inc. (NASDAQ:CSII) has risen 0.43% since May 31, 2017 and is uptrending. It has underperformed by 12.14% the S&P500.

Amedisys, Inc. (AMED) formed wedge up with $78.00 target or 4.00% above today’s $75.00 share price. Amedisys, Inc. (AMED) has $2.56 billion valuation. The stock decreased 2.42% or $1.86 during the last trading session, reaching $75. About 50,510 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 24.73% since May 31, 2017 and is uptrending. It has outperformed by 12.16% the S&P500.

Analysts await Amedisys, Inc. (NASDAQ:AMED) to report earnings on July, 25. They expect $0.78 EPS, up 25.81% or $0.16 from last year’s $0.62 per share. AMED’s profit will be $26.57 million for 24.04 P/E if the $0.78 EPS becomes a reality. After $0.79 actual EPS reported by Amedisys, Inc. for the previous quarter, Wall Street now forecasts -1.27% negative EPS growth.

Investors sentiment decreased to 1.13 in Q1 2018. Its down 0.64, from 1.77 in 2017Q4. It fall, as 21 investors sold Amedisys, Inc. shares while 57 reduced holdings. 35 funds opened positions while 53 raised stakes. 31.35 million shares or 1.46% less from 31.82 million shares in 2017Q4 were reported. Riggs Asset Managment accumulated 450 shares or 0.01% of the stock. Swiss State Bank holds 0% or 50,200 shares in its portfolio. Deutsche Bancorporation Ag invested in 0% or 105,535 shares. Pub Employees Retirement Association Of Colorado accumulated 0% or 6,050 shares. Great Lakes Advisors Lc reported 128,129 shares. Security Natl holds 0.02% of its portfolio in Amedisys, Inc. (NASDAQ:AMED) for 1,000 shares. Los Angeles Mngmt Equity Rech has 58,903 shares for 0.02% of their portfolio. Voya Investment Mngmt Ltd Llc has invested 0.13% in Amedisys, Inc. (NASDAQ:AMED). Ameriprise invested in 0.02% or 813,297 shares. Millennium Mgmt Ltd Liability Company holds 250,473 shares or 0.02% of its portfolio. Tudor Invest Corporation Et Al accumulated 0.02% or 8,598 shares. Hancock Holdings reported 0.35% stake. Ontario – Canada-based Manufacturers Life Ins Com The has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Global X Management Llc reported 0% in Amedisys, Inc. (NASDAQ:AMED). California Employees Retirement System reported 0.01% in Amedisys, Inc. (NASDAQ:AMED).

Among 15 analysts covering Amedisys Inc. (NASDAQ:AMED), 8 have Buy rating, 0 Sell and 7 Hold. Therefore 53% are positive. Amedisys Inc. has $8000 highest and $39 lowest target. $62.27’s average target is -16.97% below currents $75 stock price. Amedisys Inc. had 43 analyst reports since September 1, 2015 according to SRatingsIntel. The firm has “Hold” rating by Robert W. Baird given on Thursday, March 1. On Friday, November 10 the stock rating was maintained by Robert W. Baird with “Neutral”. The firm earned “Buy” rating on Wednesday, June 7 by Jefferies. The rating was maintained by RBC Capital Markets with “Sector Perform” on Friday, May 6. The stock of Amedisys, Inc. (NASDAQ:AMED) has “Hold” rating given on Sunday, October 22 by RBC Capital Markets. SunTrust maintained Amedisys, Inc. (NASDAQ:AMED) rating on Tuesday, April 17. SunTrust has “Buy” rating and $8000 target. Mizuho upgraded the stock to “Buy” rating in Tuesday, January 19 report. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Outperform” rating by RBC Capital Markets on Monday, March 19. As per Monday, October 9, the company rating was maintained by SunTrust. RBC Capital Markets maintained the shares of AMED in report on Thursday, November 9 with “Hold” rating.

Since May 11, 2018, it had 0 buys, and 2 sales for $1.12 million activity. $331,874 worth of stock was sold by Pearce David B. on Friday, May 11. 11,000 shares valued at $786,708 were sold by North Michael Paul on Friday, May 11.

Cardiovascular Systems, Inc., a medical technology company, develops, makes, and markets devices to treat vascular diseases in the United States. The company has market cap of $1.02 billion. The firm offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System , Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It currently has negative earnings. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries.

Among 9 analysts covering Cardiovascular Systems (NASDAQ:CSII), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Cardiovascular Systems had 25 analyst reports since August 6, 2015 according to SRatingsIntel. Needham downgraded Cardiovascular Systems, Inc. (NASDAQ:CSII) on Friday, December 15 to “Hold” rating. William Blair initiated Cardiovascular Systems, Inc. (NASDAQ:CSII) on Thursday, December 21 with “Hold” rating. The stock has “Buy” rating by Dougherty & Company on Thursday, October 8. The rating was downgraded by Needham to “Buy” on Thursday, October 8. The stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) has “Underperform” rating given on Wednesday, June 21 by Bank of America. The firm has “Sell” rating by Zacks given on Thursday, September 3. The rating was maintained by Needham with “Buy” on Wednesday, August 30. The firm has “Underperform” rating given on Thursday, October 8 by Bank of America. Needham maintained the stock with “Buy” rating in Thursday, August 3 report. The stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) has “Neutral” rating given on Thursday, August 4 by Bank of America.

Investors sentiment decreased to 0.86 in 2018 Q1. Its down 0.16, from 1.02 in 2017Q4. It dropped, as 17 investors sold Cardiovascular Systems, Inc. shares while 42 reduced holdings. 17 funds opened positions while 34 raised stakes. 26.24 million shares or 0.31% more from 26.16 million shares in 2017Q4 were reported. Great West Life Assurance Co Can has invested 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). First Republic Mngmt Inc holds 0% or 13,727 shares in its portfolio. The New York-based Gamco Invsts Et Al has invested 0.01% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Manufacturers Life Insurance Com The reported 0% of its portfolio in Cardiovascular Systems, Inc. (NASDAQ:CSII). Qs Limited Liability owns 87,766 shares. California State Teachers Retirement invested 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Moreover, Tci Wealth Incorporated has 0% invested in Cardiovascular Systems, Inc. (NASDAQ:CSII). Cambridge Invest Advsr Inc stated it has 0.01% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Credit Suisse Ag invested in 42,822 shares. Jennison Ltd stated it has 0% of its portfolio in Cardiovascular Systems, Inc. (NASDAQ:CSII). White Pine Llc reported 53,980 shares stake. Barclays Public Ltd Limited Liability Company reported 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Royal Bancshares Of Canada invested in 27,411 shares. First Light Asset Management Limited Liability Corporation invested in 2.26% or 469,687 shares. Invesco Limited stated it has 0% in Cardiovascular Systems, Inc. (NASDAQ:CSII).

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Positions Chart